1,864
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Characterization of nimbidiol as a potent intestinal disaccharidase and glucoamylase inhibitor present in Azadirachta indica (neem) useful for the treatment of diabetes

&
Pages 900-910 | Received 15 Feb 2012, Accepted 15 May 2012, Published online: 18 Jul 2012

References

  • Naoki A. Glycosidase inhibitors: Update and perspectives on practical use. Glycobiology 2003;13:93–104.
  • Clissold SP, Edwards C. Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1988;35:214–243.
  • Kim MJ, Lee SB, Lee HS, Lee SY, Baek JS, Kim D et al. Comparative study of the inhibition of α-glucosidase, α-amylase, and cyclomaltodextrin glucanosyltransferase by acarbose, isoacarbose, and acarviosine-glucose. Arch Biochem Biophys 1999;371:277–283.
  • Hansawasdi C, Kawabata J, Kasai T. α-amylase inhibitors from roselle (Hibiscus sabdariffa Linn.) tea. Biosci Biotechnol Biochem 2000;64:1041–1043.
  • Nahoum V, Roux G, Anton V, Rougé P, Puigserver A, Bischoff H et al. Crystal structures of human pancreatic α-amylase in complex with carbohydrate and proteinaceous inhibitors. Biochem J 2000;346 Pt 1:201–208.
  • Qian M, Nahoum V, Bonicel J, Bischoff H, Henrissat B, Payan F. Enzyme-catalyzed condensation reaction in a mammalian α-amylase. High-resolution structural analysis of an enzyme-inhibitor complex. Biochemistry 2001;40:7700–7709.
  • Sengupta S, Charkroborty A, Mukherjee A, Sarkar T. A process for the isolation of an α-glycosidase inhibitor, useful for non-insulin dependent diabetes treatment. C.S.I.R. Patent Application No. 0339NF, Delhi, India, 2005.
  • Sengupta S, Mukherjee A, Goswami R, Basu S. Hypoglycemic activity of the antioxidant saponarin, characterized as α-glucosidase inhibitor present in Tinospora cordifolia. J Enzyme Inhib Med Chem 2009;24:684–690.
  • Khosla P, Bhanwra S, Singh J, Seth S, Srivastava RK. A study of hypoglycaemic effects of Azadirachta indica (Neem) in normaland alloxan diabetic rabbits. Indian J Physiol Pharmacol 2000;44:69–74.
  • Sengupta S, Mukherjee A. A process for the characterization of the bioactive component present in the Bark and root of Azadirachta indica (Neem) used in herbal remedies for the treatment of diabetes. Indian Patent Journal No. 45/2008. Indian Patent Application No. 617/kol/2007, Kolkata, India, 2008.
  • Sengupta S, Jana ML, Sengupta D, Naskar AK. A note on the estimation of microbial glycosidase activities by dinitrosalicylic acid reagent. Appl Microbiol Biotechnol 2000;53:732–735.
  • Bergmeyer HU, Brent E, Schmidt E, Stork H. (1974). Enzymatic analysis of glucose. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. London: Academic Press London, 1196–1201.
  • Breitmeier D, Günther S, Heymann H. Acarbose and 1-deoxynojirimycin inhibit maltose and maltooligosaccharide hydrolysis of human small intestinal glucoamylase-maltase in two different substrate-induced modes. Arch Biochem Biophys 1997;346:7–14.
  • Sengupta S, Mukherjee A. Characterization of nimbidiol as an α-glucosidase inhibitor present in neem (Azadirachta indica), useful for non-insulin dependent diabetes treatment. Indian Patent Application No. 768/KOl/2011, Kolkata, India, 2011.
  • Buckingham J. (1994). Dictionary of natural products. London, UK: Chapman and Hall, 1794.
  • Majumder PL, Maiti DC, Kraus W, Bokel M. Nimbidiol, a modified diterpenoid of the root-bark of Azadirachta indica. Phytochemistry 1987;26:3021–3023.
  • Ara I. (1989). Studies in the chemical constituents of Azadirachta indica (neem). PhD Thesis. Karachi, Pakistan: University of Karachi/H.E.J Research Institute of Chemistry, 149–151.
  • Sim L. (2010). Structural and inhibition studies of human intestinal glucosidases. PhD Thesis. Toronto, Canada: Graduate Department of Medical Biophysics, University of Toronto, 8–12.
  • Kameda Y, Asano N, Yoshikawa M, Takeuchi M, Yamaguchi T, Matsui K et al. Valiolamine, a new α-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus. J Antibiot 1984;37:1301–1307.
  • Yagi M, Kouno T, Aoyagi Y, Murai H. The structure of maranoline, a piperidine alkaloid from Morus species. Nippon Nogei Kagaku Koishi 1976;50:571–572.
  • Schmidt DD, Frommer W, Müller L, Truscheit E. [Glucosidase inhibitors from Bacilli]. Naturwissenschaften 1979;66:584–585.
  • Osonoi T, Saito M, Mochizuki K, Fukaya N, Muramatsu T, Inoue S et al. The a-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus. Metab Clin Exp 2010;59:1816–1822.
  • Yoshikawa M, Murakami T, Shimada H, Matsuda H, Yamahara J, Tanabe G, Muraoka O. Salacinol, potent antidiabetic principle with unique thiosugar sulfonium sulfate structure from the Ayurvedic traditional medicine Salacia reticulata in Sri Lanka and India. Tetrahedron Lett 1997;38: 8367–8370.
  • Yoshikawa M, Murakami T, Yashiro K, Matsuda H. Kotalanol, a potent α-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata. Chem Pharm Bull 1998;46:1339–1340.
  • Zambrano JL, Rosales V, Nakano T. First formal synthesis of (+)-nimbidiol. Synthesis, X-ray structure and anticancer activity of a novel ring C aromatic diterpene: Dimethyl (+)-podocarpa-8,11,13-triene-12,13-dicarboxylate. Tetrahedron Lett 2003;44:1859–1862.
  • Samulitis BK, Goda T, Lee SM, Koldovský O. Inhibitory mechanism of acarbose and 1-deoxynojirimycin derivatives on carbohydrases in rat small intestine. Drugs Exp Clin Res 1987;13:517–524.
  • Gao H, Huang YN, Xu PY, Kawabata J. Inhibitory effect on á-glucosidase by the fruits of Terminalia chebula. Retz Food Chem 2007;105:628–634.
  • Gao H, Huang YN, Gao B, Kawabata J. Chebulagic acid is a potent α-glucosidase inhibitor. Biosci Biotechnol Biochem 2008;72:601–603.
  • Gao H, Huang YN, Gao B, Xu PY, Inagaki C, Kawabata J. α-Glucosidase inhibitory effect by the flower buds of Tussilago farfara L. Food Chem 2008;106:1195–1120.
  • Matsuda H, Morikawa T, Yoshikawa M. Anti-diabetogenic constituents from several natural medicines. Pure Appl Chem 2002;74:1301–1308.
  • Hanozet G, Pircher HP, Vanni P, Oesch B, Semenza G. An example of enzyme hysteresis. The slow and tight interaction of some fully competitive inhibitors with small intestinal sucrase. J Biol Chem 1981;256:3703–3711.
  • Schmidt DD, Frommer W, Junge B, Müller L, Wingender W, Truscheit E et al. α-Glucosidase inhibitors. New complex oligosaccharides of microbial origin. Naturwissenschaften 1977;64:535–536.
  • Kim JH, Ryu YB, Kang NS, Lee BW, Heo JS, Jeong IY et al. Glycosidase inhibitory flavonoids from Sophora flavescens. Biol Pharm Bull 2006;29:302–305.
  • Du ZY, Liu RR, Shao WY, Mao XP, Ma L, Gu LQ et al. α-glucosidase inhibition of natural curcuminoids and curcumin analogs. Eur J Med Chem 2006;41:213–218.
  • Tadera K, Minami Y, Takamatsu K, Matsuoka T. Inhibition of α-glucosidase and α-amylase by flavonoids. J Nutr Sci Vitaminol 2006;52:149–153.
  • Hakamata W, Nakanishi I, Masuda Y, Shimizu T, Higuchi H, Nakamura Y et al. Planar catechin analogues with alkyl side chains: A potent antioxidant and an α-glucosidase inhibitor. J Am Chem Soc 2006;128:6524–6525.
  • Prabhakar Reddy P, Tiwari AK, Ranga Rao R, Madhusudhana K, Rama Subba Rao V, Ali AZ et al. New Labdane diterpenes as intestinal α-glucosidase inhibitor from antihyperglycemic extract of Hedychium spicatum (Ham. Ex Smith) rhizomes. Bioorg Med Chem Lett 2009;19:2562–2565.
  • Wafo P, Kamdem RS, Ali Z, Anjum S, Begum A, Oluyemisi OO et al. Kaurane-type diterpenoids from Chromoleana odorata, their X-ray diffraction studies and potent a-glucosidase inhibition of 16-kauren-19-oic acid. Fitoterapia 2011;82:642–646.
  • Ayinampudi SR, Domala R, Merugu R, Bathula S, Janaswamy MR. New icetexane diterpenes with intestinal a-glucosidase inhibitory and free-radical scavenging activity isolated from Premna tomentosa roots. Fitoterapia 2012;83:88–92.
  • Miyahara C, Miyazawa M, Satoh S, Sakai A, Mizusaki S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J Nutr Sci Vitaminol 2004;50:161–164.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.